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Abstract
Background: Much research effort has been focused on investigating new compounds derived from low-cost
sources, such as natural products, for treating leishmaniasis. Oleuropein derived from numerous plants, particularly
from the olive tree, Olea europaea L. (Oleaceae), is a biophenol with many biological activities. Our previous findings
showed that oleuropein exhibits leishmanicidal effects against three Leishmania spp. in vitro, and minimizes the
parasite burden in L. donovani-infected BALB/c mice. The aim of the present study is to investigate the possible
mechanism(s) that mediate this leishmanicidal activity.
Methods: We determined the efficacy of oleuropein in elevating ROS and NO production in L. donovani-infected
J774A.1 macrophages and in explanted splenocytes and hepatocytes obtained from L. donovani-infected BALB/c
mice. We also assessed the expression of genes that are related to inflammation, T-cell polarization and antioxidant
defense, in splenocytes. Finally, we determined the ratios of specific IgG2a/IgG1 antibodies and DTH reactions in L.
donovani-infected BALB/c mice treated with oleuropein.
Results: Oleuropein was able to elevate ROS production in both in vitro and in vivo models of visceral leishmaniasis
and raised NO production in ex vivo cultures of splenocytes and hepatocytes. The extensive oxidative stress found in
oleuropein-treated mice was obviated by the upregulation of the host’s antioxidant enzyme (mGCLC) and the
simultaneous downregulation of the corresponding enzyme of the parasite (LdGCLC). Moreover, oleuropein was able
to mount a significant Th1 polarization characterized by the expression of immune genes (IL-12β, IL-10, TGF-β1, IFN-γ)
and transcription factors (Tbx21 and GATA3). Moreover, this immunomodulatory effect was also correlated with an
inhibitory effect on IL-1β gene expression, rather than with the expression of IL-1α, IL-1rn and TNF-α. Furthermore,
oleuropein-treated BALB/c mice mounted a delayed-type hypersensitivity (DTH) response and an elevated
Leishmania-specific IgG2a/IgG1 ratio that clearly demonstrated an in vivo protective mechanism.
Conclusion: The ability of Oleuropein to promote a Th1 type immune response in L. donovani-infected BALB/c mice
points towards the candidacy of this bioactive compound as an immunomodulatory agent that may complement
therapeutic approaches to leishmaniasis.
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Background
Leishmaniasis is a parasitic disease with diverse clinical
manifestations. The parasites of the genus Leishmania
have developed the ability to manipulate the cells of the
host immune system and to survive within the macro-
phage phagolysosome. After establishment, Leishmania
infection per se is able to alter the immunological and
inflammatory host responses to its own benefit [1, 2].
To date, much research effort has been directed to-
wards the discovery of new therapeutic agents capable
of killing the majority of Leishmania species and pro-
moting the host immune response. This activity of
potent therapeutic agents must rely on the generation
of a strong immune response orchestrated by both innate
and adaptive immunity against Leishmania infection. The
differentiation and proliferation of specific CD4+ T cells
(T-helper cells) into different effector cell subpopulations
have been recognized. Indicatively, Th1, Th2, and Th3
have been identified in murine visceral leishmaniasis
through their landmark produced cytokines, interleukin-
12 (IL-12), IL-10, and transforming growth factor-β (TGF-
β), respectively. There has been a consensus that a Th1
dominant response over that of Th2, is responsible for the
activation of macrophages that eliminate Leishmania par-
asites via microbicidal molecules, such as reactive oxygen
species (ROS) and nitric oxide (NO) [3]. The polarization
of Th cells into Th1 and Th2 effector cells is controlled by
the regulation and production of the transcription factors
T-box transcription factor (Tbx21) and trans-acting T-
cell-specific transcription factor (GATA3), respectively [4].
The regulation of GATA3 expression is considered essen-
tially significant, because its downregulation allows the
production of Tbx21 which is mainly stimulated by Th1-
related cytokines, like IL-12 and interferon-γ (IFN-γ) [5,
6]. Moreover, GATA-3 regulation is maintained by the
presence of the immunosuppressing cytokine IL-10 and
not IL-4 [7, 8]. On the contrary, the presence of TGF-β
can halt the differentiation and the proliferation of imma-
ture T-cells into the above discrete subpopulations. These
differential immune responses are also correlated with the
existence of inflammatory messengers after the onset of
disease or during parasite dissemination that will render a
strengthened Th2-Th3 immune response allowing the
gradual spread of the disease [9–12].
The Th1 immune response induces macrophages to
generate leishmanicidal molecules, such as ROS and
reactive nitrogen intermediates (RNI), like NO [13].
Among the various types of ROS, superoxide anion (O2
-)
is largely produced at the establishment of infection dur-
ing the penetration of promastigotes to macrophages,
while lower amounts are produced during the outspread
of disease and the infection of adjacent monocytes with
amastigotes. It has been shown that this reduction is
mainly due to a NADPH oxidase deficiency that is being
imposed by the intracellular parasite [14–16]. NO is the
other anti-leishmanial molecule and its production is
catalyzed by the inducible nitric oxide synthase enzyme
(iNOS) from L-arginine. Contrary to ROS, NO is pro-
duced in the macrophage response against the parasites
already present within the cell [17]. This is due to the
fact that iNOS induction and its transformation into an
active form requires at least 6 h after synergism of vari-
ous stimuli, such as cytokines (IL-12, IL-18, IFN-γ,
tumor necrosis factor-α; TNF-α), microbial products
and elements such as lipopolysaccharide (LPS), co-
stimulatory molecules, adhesion molecules, as well as
immune complexes [6, 18]. Leishmania spp. parasites
possess the glutamate-cysteine ligase enzyme (GCL or γ-
GCS), which is involved in biosynthesis of the antioxi-
dant molecule named trypanothione (TSH). TSH confers
control on the oxidative potential within the host’s
phagolysosomes, which allows the parasites to avoid
the deleterious effects of ROS and NO [19]. On the
other hand, host cells have similar molecules like
glutathione (GSH) and an analogue “host” GCL [20]
which protect them from extensive oxidative stress
that occurs during the defense against phagocytized
parasites and the production of microbicidal molecules
[16, 21]. Protozoans of the genus Leishmania prefer
TSH for their protection against ROS and NO because
TSH has a 600-fold higher affinity binding to NO than
GSH [22, 23]. Nevertheless, transgenic promastigotes
that were heterozygous for GCL produced reduced
levels of TSH and became vulnerable to oxidative
stress in vitro and exhibited reduced survival within
activated macrophages [23].
The activation of macrophages and the subsequent
production of ROS and NO are inextricably associated
with the host’s defense against leishmaniasis. However,
this production must be accompanied by an acute regula-
tion of antioxidant enzymes to defend against the oxida-
tive burst. The differential regulation of the host and
parasite antioxidant systems results in an armored protec-
tion for host cells, and in contrast, an impaired defense
for the parasites. Throughout the literature, several natural
products have been tested for their ability to increase the
production of ROS and/or NO in in vitro and in vivo ex-
perimental models of leishmaniasis. Some natural plant
products, including taxoid 10-deacetylbacattin-III [24],
monoterpene linalool [25], 2′,6′-dihydroxy-4′-methoxy-
chalcone [26], and crude leaf extracts from Chenopodium
ambrosioides L. (Amaranthaceae) [27], were shown to
stimulate macrophages to increase NO production during
Leishmania infection. Furthermore, some natural animal
products, like the venom from Bungarus caeruleus
Schneider, 1801 (Elapidae) were shown to promote ROS
and NO production in an in vivo experimental visceral
leishmaniasis model [28].
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Oleuropein (Ole), a secoiridoid present in olives and
leaves of Olea europaea L. (Oleaceae), was previously
shown to induce reduced parasite burden in BALB/c
mice infected with Leishmania donovani (Laveran &
Mesnil, 1903) (Trypanosomatidae) even six weeks after
the termination of treatment [29]. Moreover, it has been
shown that Ole is able to induce apoptotic mechanisms
in several cancer cell lines without regulating the expres-
sion of molecules involved in the NF-kB signaling path-
way (e.g. MAPK cascade proteins, IkB-α) [30, 31].
Furthermore, Ole has been shown to be able to refill the
cellular antioxidant pool by upregulating glutathione-
recovery enzyme expression [32] and to decrease inflam-
matory mediator production (IL-1β) by human whole
blood cultures [33]. The anti-inflammatory efficacy of
Ole might contribute to Leishmania spp. clearance, be-
cause IL-1β abrogation results in Th1 polarization [34].
In the present study, we aimed to determine the pos-
sible mechanism by which Ole is able to promote antil-
eishmanial activity in J774A.1 macrophages infected by
L. donovani and in target tissues (spleen and liver) of L.
donovani-infected BALB/c mice. This study elucidates
the selective anti-inflammatory ability of Ole, which fa-
vours a Th1 type cell polarization of the susceptible
mouse strain challenged with viscerotropic Leishmania
parasites. This Th1 polarized immune response is illus-
trated by the regulation of Th1 specific genes such as IL-
12β, IFN-γ and TNF-α over Th2- and Th3-related genes
such as IL-10 and TGF-β1 [35, 36]. The Th1 dominance
is further confirmed by the elevated ratios of Tbx21/
GATA3 transcription factors and Leishmania-specific
IgG2a/IgG1 antibodies in the spleen and serum of in-
fected BALB/c mice treated with Ole. The above cascade
induces the in vivo production of microbicidal molecules
like ROS and NO. Moreover, in this study we demon-
strated the ability of Ole to promote host antioxidant
defense mechanism(s) in the host, whereas it is able to
downregulate the corresponding parasite antioxidant
defense. These findings were further complemented with
the detection of delayed-type hypersensitivity response




The viscerotropic Leishmania strain L. donovani (zymo-
deme MON-2, strain MHOM/IN/1996/THAK35) was
kindly provided by Dr. K. Soteriadou (Laboratory of Mo-
lecular Parasitology, Hellenic Pasteur Institute, Greece).
Promastigotes were cultured in complete RPMI-1640
medium which consisted of RPMI-1640 with low phenol
red content (Biochrom AG, Berlin, Germany), supple-
mented with 2 mM L-glutamine, 10 mM HEPES, 24 mM
NaHCO3, 100 U/ml penicillin, 100 μg/ml streptomycin,
and 10 % v/v heat-inactivated fetal bovine serum (FBS;
Gibco, Paisley, UK). Promastigotes were grown at 26 °C in
a cell culture flask.
Macrophage culture and in vitro infection protocol
The immortalized macrophage cell line J774A.1 was pur-
chased from the American Type Culture Collection
(ATCC; Rockville, MD, USA/ ATCC No: TIB-67). The
J774A.1 cells were cultured in culture flasks with
complete RPMI-1640 medium and were incubated at
37 °C in a 5 % CO2 environment. The viability of
J774A.1 cells was determined by Trypan blue staining
and cells were counted in a Malassez hemocytometer.
Adherent J774A.1 cells were infected in vitro with L.
donovani stationary-phase promastigotes at a ratio of
1:15 for 4 h, as previously described [29].
Natural product
Oleuropein (Ole) with purity of above 95 %, was ex-
tracted from air-dried, pulverized leaves (5 kg) of Olea
europaea var koroneiki collected in Crete (Greece)
[29]. Ole was diluted in distilled water, Millipore fil-
tered with a 0.45 μm pore size filter (Millipore, Mas-
sachusetts, USA) and stored at 4 °C.
For the conduct of the in vitro experiments, Ole
was used at two different concentrations, 128.4 μM
(69.4 μg/ml), which represents the half maximal
inhibitory concentration (IC50) against L. donovani
promastigotes of logarithmic phase and 256.8 μM
(138.8 μg/ml; i.e. 2× IC50) [29].
Production of soluble Leishmania antigen
Soluble Leishmania Antigen (SLA) was derived from
109 L. donovani stationary phase promastigotes. Briefly,
promastigotes were placed in sterile phosphate buffered
saline (PBS) and then disrupted with three repeated
freeze-thaw cycles (freezing at -80 °C and thawing at
37 °C). Lysed parasites were then sonicated 3 times for
1 min, at 30-s intervals. The crude lysate was centrifuged
at 8,000× g for 30 min at +4 °C, and the supernatant was
aliquoted and stored at -80 °C until use. The protein
concentration of SLA was measured with a NanoDrop
2000 spectrophotometer (Thermo Fischer Scientific,
Waltham, MA).
In vivo visceral leishmaniasis experimental protocol
Age-matched 8 to 10-week-old female BALB/c mice
(20–25 g) were obtained from the breeding unit of the
Hellenic Pasteur Institute (HPI, Athens, Greece). Experi-
mental protocols were approved by the Animal Bioethics
Committee of the HPI, according to the regulations of
the European Commission Directive 1986/609 and the
National Law of 1992/2015.
Kyriazis et al. Parasites & Vectors  (2016) 9:441 Page 3 of 16
Briefly, BALB/c mice were infected intravenously in
the lateral vein with 1.5 × 107 L. donovani stationary-
phase promastigotes. At 15 days post-infection, animals
were randomly assigned to five groups. In the first three
experimental groups (G1, G2, G3), Ole was administered
intraperitoneally at three different concentrations (45,
15, or 5 mg/kg body weight (b.w.) of pure Ole, respect-
ively), every other day, for up to 28 days. The fourth ex-
perimental group (G4), representing the positive control
group, received miltefosine (HePC), the only drug ap-
proved by the Food and Drug Administration agency of
USA (USFDA) for treating leishmaniasis. HePC (4 mg/
kg b.w.), was administered by daily oral gavage for up to
28 days. BALB/c mice of the fifth group (G5 infected
control group) did not receive any treatment. Finally, a
group of non-infected mice (G6) served as the healthy
control group (negative control group). Spleens, livers,
and blood serum samples were obtained at 3 days and
6 weeks after treatment termination.
Assessment of generalized intracellular oxidative stress
To detect general intracellular oxidative stress, 107 cells/
ml of each in vitro or in vivo experimental group were
incubated with 5 μM of a ROS-sensitive fluorescent
probe (CM-H2DCFDA; a chloromethyl derivative of 2′,
7′-dichlorodihydrofluorescein diacetate, Invitrogen -Mo-
lecular Probes™) for 45 min in the dark, at 37 °C in a
5 % CO2 environment.
More specifically, for the in vitro assays, J774A.1 cells
(L. donovani-infected and non-infected) were incubated
for 24 h with Ole (69.4 or 138.8 μg/ml) either alone or
in the presence of LPS (1 μg/ml); LPS (1 μg/ml) alone;
or LPS (1 μg/ml) plus IFN-γ (1 ng/ml) which represent
the positive control groups of the applied method.
Concerning the in vivo assays, explanted splenocytes
were directly incubated with CM-H2DCFDA, except for
splenocytes derived from the mice of the negative-
control group, which were incubated for 5 min with
hydrogen superoxide (10 μM, H2O2), before incubation
with CM-H2DCFDA. The cells of each experimental
group were washed with PBS and then placed at 4 °C.
Subsequently, 10,000 cells per experimental group
were analyzed with Fluorescence-Activated Cell Sorting
(FACS; on a FACS Calibur apparatus, Becton-Dickinson,
San Jose, CA, USA). ROS activity was evaluated in terms
of the geometric mean fluorescence intensity (gMFI).
The results were plotted with Cell Quest (Becton Dick-
inson) and Flowjo (TreeStar Inc., Ashland, USA)
software.
Quantification of extracellular nitric oxide (NO)
NO levels in the supernatants of all experimental groups
were determined with the Griess reaction (Sigma-Aldrich,
USA), as described before [37].
J774A.1 cells were incubated for 24 h with 69.4 or
138.8 μg/ml of Ole, either alone or in combination with
LPS (1 μg/ml), LPS (1 μg/ml) alone, or LPS (1 μg/ml)
plus IFN-γ (1 ng/ml). The stimuli described above were
placed before and after the L. donovani infection for up to
24 h and NO levels were determined in the supernatant of
the cultures. NO levels were also determined in unin-
fected J774A.1 cells treated with the same stimuli.
Ex vivo splenocytes and hepatocytes were cultured in
the presence of complete RPMI-1640 medium and NO
levels were determined after 24 h. Furthermore, spleno-
cytes and hepatocytes obtained from the non-infected
mice (G6 group) were incubated in the presence of LPS
(1 μg/ml) or LPS (1 μg/ml) plus IFN-γ (1 ng/ml).
The optical density of the Griess reaction products
was measured at 570 nm with a spectrophotometer
(MRX, DYNATECH Laboratories, Guernsey, England).
Gene expression analysis in splenocytes of L.
donovani-infected BALB/c mice
Splenocytes were obtained from L. donovani-infected
BALB/c mice of all experimental groups, 3 days after
treatment termination. Total mRNA was isolated with
an RNeasy Mini kit (Qiagen, Germany), and mRNA con-
centrations were measured with a NanoDrop 2000 spec-
trophotometer (Thermo Fischer Scientific). Messenger
RNA was then reverse-transcribed using a SuperScript II
kit (Invitrogen -Molecular Probes™) and oligo-dTs (Pro-
mega, WI, USA), and all reactions included the recom-
binant ribonuclease inhibitor, RNaseOUT™ (Invitrogen).
cDNAs of all the in vivo experimental groups were eval-
uated with real time PCR, performed using an Exicycler
96 thermocycler (Bioneer, Daejeon, Korea), using the Kapa
SYBR Fast Universal 2× qPCR Master Mix kit (Kapa Bio-
systems Ltd., London, UK). The specific primers for the
interleukin-1α (IL-1α), interleukin-1β (IL-1β), interleukin-
1 receptor antagonist (IL-1rn), interleukin-10 (IL-10), sub-
unit 2 of interleukin-12 (IL-12β), interferon-γ (IFN-γ),
tumor necrosis factor-α (TNF-α), transforming growth
factor beta-1 (TGF-β1), T-box transcription factor
(Tbx21), trans-acting T-cell-specific transcription factor
(GATA3), subunit 2 of nuclear factor kappa-B (NF-kB2),
and the glyceraldehyde dehydrogenase of the 3-
phosphatase (GAPDH) gene sequences were designed by
Qiagen (QuantiTect Primer Assays; Qiagen, Venlo,
Netherlands). The primers used to target the murine and
L. donovani glutamate-cysteine ligase catalytic subunit
sequences (mGCLC and LdGCLC, respectively) and the L.
donovani a-tubulin gene sequence (LdAtub) were de-
scribed previously [38, 39]. The PCR was conducted ac-
cording to Qiagen’s PCR protocol for the QuantiTect
Primer Assays. All gene expression ratios were computed
with the ΔΔCt method [40]. All qPCR experiments were
performed in 3 replicates for each experimental condition.
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Detection of Leishmania-specific IgG antibodies
Blood from L. donovani-infected BALB/c mice was collected
at 3 days and 6 weeks after the termination of the treat-
ments. Serum was separated upon centrifugation of blood
at 4000× g for 5 min. The Leishmania-specific IgG1 and
IgG2a antibodies were determined with an indirect ELISA
method. Briefly, 96-well microtiter plates were coated with
5 μg/ml of SLA in carbonate buffer (15 mM Na2CO3,
35 mM NaHCO3), pH 9.6 and left overnight at 4 °C. For the
detection of IgG1 and IgG2a isotypes, serum samples (1/
100 dilution) were added, as described previously [41].
Measurement of Delayed Type Hypersensitivity (DTH)
In order to determine the delayed hypersensitivity reac-
tions, BALB/c mice that had been treated with Ole
(15 mg/kg b.w.), were intradermally administered with
total soluble L. donovani antigen (20 μg dissolved in
20 μl of sterile PBS) in the left hind footpad, 3 days
post-treatment termination. As a negative control, the
right hind footpad was given an equal volume of sterile
PBS. The DTH response was determined by measuring
the increase in thickness between the two hind footpads,
for up to 48 h. Footpad swelling was measured with a
dial gauge caliper (Mitutoyo, Kanagawa, Japan) and the
difference was based on the following formula: Footpad
swelling (mm) = thickness of left footpad – thickness of
right footpad. The DTH was also determined in non-
infected and in infected and non-treated BALB/c mice.
Statistical analysis
Three independent experiments were performed in
duplicate for each in vitro method used. The in vivo ex-
perimental protocol was conducted twice and each
group consisted of 6 mice. Statistical differences between
the means of the in vitro (P ≤ 0.05) and ex vivo (P ≤ 0.1)
experiments were analyzed for significance with the
non-parametric Mann-Whitney test.
Results
Oleuropein induces intracellular ROS and nitric oxide
production in J774A.1 cells
Increased intracellular levels of ROS and extracellular
production of NO indicate macrophage activation via
the classical pathway and parasite clearance [3]. We first
determined the effect of Ole in the generation of ROS in
infected or non-infected J774A.1 macrophages. Non-
infected J774A.1 cells (dark grey bars in Fig. 1) that were
incubated with 138.8 μg/ml of Ole exhibited significantly
higher levels of intracellular ROS (gMFI = 6 ± 0.2) com-
pared to the corresponding levels generated by untreated
J774A.1 cells (gMFI = 4.3 ± 1.1, P = 0.05). Nevertheless, Ole
was not able to strengthen the intracellular oxidative stress
caused by LPS, which is a potent stimulator of macro-
phages. More specifically, J774A.1 cells that were incubated
with Ole plus LPS, did not exhibit augmentation of intra-
cellular ROS compared to J774A.1 cells that were stimu-
lated only with LPS (gMFI = 9.1 ± 2.4).
Moreover, L. donovani-infected J774A.1 cells (light
gray bars in Fig. 1) that were treated with Ole, exhibited
significantly (P ≤ 0.05) higher intracellular ROS levels
than their respective control groups. More specifically,
L.donovani-infected J774A.1 cells that were treated with
69.4 and 138.8 μg/ml of Ole, exhibited high geometric
mean fluorescence indexes (9 ± 0.1 and 8.4 ± 0.2, respect-
ively; P = 0.05), when the corresponding mean for non-
treated and infected J774A.1 cells was determined at 6.1 ±
0.2 gMFI (Fig. 1). Furthermore, it is noteworthy that L.
donovani-infected J774A.1 cells that were simultaneously
incubated with Ole (138.8 μg/ml) and LPS managed to
exert increased ROS production (gMFI = 11 ± 0.7; P =
0.05) in comparison to infected cells treated only with LPS
(gMFI = 9.1 ± 0.6), whereas infected cells that were treated
with 69.4 μg/ml of Ole plus LPS, exhibited significantly di-
minished ROS production (gMFI = 7.1 ± 0.6; P = 0.05,
Fig. 1). These data indicate the differential effect of Ole in
inducing ROS production in vitro, depending on different
parameters such as the concentration of Ole, the parasite
challenge or the simultaneous activation with LPS.
Fig. 1 ROS levels in uninfected and L. donovani-infected J774A.1
macrophages. The negative control is represented by uninfected
and untreated J774A.1 macrophages while the positive controls are
represented by L. donovani-infected J774A.1 cells incubated with either
LPS alone or with LPS plus IFN-γ. *indicates significant differences
compared to the negative control group; Zindicates significant
differences compared to the positive control (LPS) group; #indicates
significant differences between the two different concentrations of Ole
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In addition, in uninfected J774A.1 cells Ole promoted a
significant (P = 0.05) increase in nitrite production
(0.069 ± 0.008 μg/ml; Fig. 2) compared to the baseline
level (negative control, 0.053 ± 0.002 μg/ml).
However, Ole did not augment extracellular NO levels
in L. donovani-infected J774A.1 cells, regardless of
whether it was added before or after the infection or
alone or in combination with LPS (Fig. 2).
Oleuropein induces high oxidant production in spleen
and liver cells
The levels of intracellular ROS were determined in sple-
nocytes of L. donovani-infected BALB/c mice, 3 days
and 6 weeks after the termination of Ole or HePC
treatment.
At 3 days post-termination of treatment (dark grey
bars in Fig. 3a), splenocytes exhibited a significant in-
crease in the levels of intracellular ROS in response to
Ole. Splenocytes of mice that had been treated with 45,
15 and 5 mg/kg b.w. of Ole, exhibited inflated levels of
ROS reaching 65.5 ± 19.6 (P = 0.004), 39.8 ± 16.3 (P =
0.004) and 14.4 ± 1.6 gMFI (P = 0.004), respectively,
compared to splenocytes of infected and non-treated
mice (infected control group, G5; gMFI = 6.0 ± 2.0). It
is noteworthy that splenocytes obtained from L. dono-
vani-infected BALB/c mice treated with HePC (posi-
tive control group), did not exhibit high levels of
ROS (gMFI = 7 ± 1.2; Fig. 3a). Moreover, it is import-
ant that although we observed significant production
of ROS in splenocytes of Ole-treated mice at 3 days post-
termination of treatment, we did not notice any significant
production of ROS at 6 weeks post-termination of treat-
ment in all experimental groups.
Subsequently, we determined the levels of NO in the
supernatant of spleen and liver cells that were explanted
from all the in vivo experimental groups. At 3 days after
treatment termination (light grey bars in Fig. 4), single
cell suspensions obtained from spleen and liver tissues
from Ole- or HePC-treated mice (G1-G4) showed a signifi-
cant increase in NO levels compared to the infected control
group (G5) (Fig. 4). As shown in Fig. 4, in splenocytes from
BALB/c mice treated with Ole or HePC, the levels of NO
were 0.2 ± 0.052 μg/ml for G1 (P = 0.004), 0.278 ± 0.048 μg/
ml for G2 (P = 0.004), 0.299 ± 0.054 μg/ml for G3 (P =
0.004) and 0.299 ± 0.047 μg/ml for G4 (P = 0.004), whereas
the corresponding levels for G5 (infected control group)
and G6 (healthy control group) were 0.1 ± 0.045 and 0.07 ±
0.053 μg/ml, respectively. In addition, explanted liver cell
supernatants exhibited similar nitrite production (Fig. 4b).
At 3 days post-termination of treatment, only mice from
G1 and G2 groups (treated with Ole 45 and 15 mg/kg b.w.,
respectively) showed significant increases in NO levels
(0.309 ± 0.025; P = 0.004 and 0.241 ± 0.081 μg/ml; P = 0.004,
respectively) compared to the infected control group (G5:
0.091 ± 0.027 μg/ml). Similarly, treatment with HePC in-
creased significantly the levels of NO in hepatocytes (0.482 ±
0.227 μg/ml, P = 0.004) (Fig. 4b). Cells treated with LPS
(P = 0.02) and LPS/IFN-γ (P = 0.02) produced significant
Fig. 2 NO levels in J774A.1 macrophage culture supernatants. Infected groups represent macrophages infected with L. donovani promastigotes.
*indicates significant differences between the two conditions indicated with brackets
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amounts of NO in their supernatant compared to
healthy control groups (Fig. 4a, b).
Finally, at 6 weeks post-treatment, the levels of nitrites
in the supernatant of the splenocytes and hepatocytes
were not significantly different among all experimental
groups (Fig. 4a, b).
Oleuropein induces Leishmania-specific IgG1 and IgG2a
antibody production
Leishmania-specifc IgG1 and IgG2a antibodies were
detected in the serum of L. donovani-infected BALB/c
mice, upon their treatment with either Ole or HePC. At




Fig. 3 a Intracellular ROS levels in splenocytes of BALB/c mice at 3 days or 6 weeks after treatment termination. # and * indicate significant
differences, compared to infected and healthy (negative) control groups, respectively. Z indicates statistically significant differences between the
Ole-treated groups indicated with brackets. b-e Representative flow cytometry histograms derived from experimental groups at 3 days after treatment
termination. Blue and pink curves represent ROS levels in healthy control and infected control groups, respectively. Red curves represent ROS levels
induced by H2O2 in uninfected splenocytes. Green curves represent ROS levels in infected splenocytes that received the indicated treatments
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significant and dose-dependent increase of the ratio
IgG2a/IgG1 in mice that were treated with Ole (light
grey bars in Fig. 5). More specifically, in mice treated
with 45 and 15 mg/kg b.w. of Ole (G1 and G2), the
IgG2a/IgG1 ratios were 2.96 and 0.8, respectively. These
ratios were 5.75-fold (P = 0.004) and 1.55-fold (P = 0.004)
greater than the corresponding ratio in the infected con-
trol group (G5). These results show that B-cell antibody
production in Ole-treated mice is being guided by a
mixed T-cell population where Th1 phenotype is being
elevated. On the other hand, HePC-treated mice did not
mount a significant IgG2a increase, indicating a mixture
of Th1/Th2 immune responses.
At 6 weeks after termination of treatment (dark grey
bars in Fig. 5), IgG2a/IgG1 ratios in Ole-treated mice
(45 and 15 mg/kg b.w.) were maintained at higher levels
compared to the infected control group (G5).
Levels of NF-kB2, murine GCLC and L. donovani GCLC
gene expression
The presence of high oxidative stress in the tested tis-
sues is likely to affect both the normal functioning of the
host cells as well as the parasites. This toxic biochemical
environment caused by the oxidative burst is accompan-
ied by changes in transcriptional levels of antioxidant-
related genes like NF-kB2 and GCLC.
At 3 days after treatment termination, the expression
levels of NF-kB2 gene in mice of the infected control
group (G5) were significantly higher (P = 0.004) com-
pared to all of the other experimental groups (G1-G4
and G6; Fig. 6). Specifically, NF-kB2 expression in
infected control was 23.18-fold upregulated compared
to healthy and untreated mice (G6). Ole-treated ex-
perimental groups exhibited at most 20.8-fold de-
crease in NF-kB2 expression compared to the infected
control group (G5).
Furthermore, as shown in Fig. 6, the mGCLC gene ex-
pression in mice from the infected control group (G5)
tended to be higher than the corresponding expression
observed in mice of the healthy control group (G6;
2.56-fold; P = 0.086). This is possibly attributed to the
presence of uncontrolled dissemination of L. donovani
infection. Moreover, all of the Ole-treated groups (G1,
G2, G3) exhibited increased mGCLC expression com-
pared to infected mice (G5), but only mice treated with
15 mg/kg b.w. of Ole showed a tendency for higher ex-
pression levels (3.17-fold; P = 0.086).
The expression of parasite GCLC (LdGCLC) was
highly elevated in infected and HePC-treated mice
compared to Ole-treated mice. More specifically,
HePC-treated mice demonstrated a 1.62-fold upregulation
a) b)
Fig. 4 NO levels in the supernatant of splenocytes (a) and hepatocytes (b) of L. donovani-infected mice upon treatment with Ole or HePC. NO
levels were determined at 3 days or 6 weeks after treatment termination. # and * indicate significant differences compared to the infected and
positive (HePC-treated) control groups, respectively. ◊ and ^ indicate significant differences compared to explanted cells from uninfected and
untreated mice that received LPS and LPS plus IFN-γ
Fig. 5 Leishmania-specific antibody production. The IgG2a/IgG1
ratios were determined in L. donovani-infected BALB/c mice upon
their treatment with Ole or HePC. Ratios were measured at 3 days
and 6 weeks after treatment termination. *indicates significant
differences compared to infected control group; Zindicates significant
differences between groups indicated with brackets
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(P = 0.014) in LdGCLC expression compared to the in-
fected control. These elevated transcription levels in in-
fected control, reflect the extreme necessity of L. donovani
parasites to upregulate one of the most important genes
involved in protection against increased oxidative stress.
On the other hand, Ole exhibited a different mode of ac-
tion from HePC. Although both HePC and Ole increased
oxidative stress (mainly by NO production), in infected
splenocytes, all Ole treatments caused a 100-fold repres-
sion (Ole45: P = 0.009; Ole15: P = 0.014; Ole5: P = 0.024)
in LdGCLC expression compared to the infected control.
Levels of IL-1rn, IL-1β, and IL-1a gene expression
Visceral leishmaniasis is a systemic inflammatory disease
and its severity is determined by the capacity of the host
immune system to control inflammation. The transcription
of inflammation-related genes is critical for the development
of such cellular micro-environment that allows or prevents
parasitic spread [2]. Moreover, one well-known characteris-
tic of Ole is its anti-inflammatory efficacy [42].
In this study, we demonstrated that the intraperitoneal
administration of Ole in L. donovani-infected BALB/c
mice was able to downregulate the expression of both
IL-1β and IL-1rn, but not IL-1α, which was found to be
upregulated (Fig. 7).
Mice treated with 45 mg/kg b.w. of Ole (G1) exhibited
a significant 20.4-fold (P = 0.025) decrease in IL-1β gene
expression compared to the infected control group (G5),
while the HePC treatment did not significantly alternate
the IL-1β expression (Fig. 7). Moreover, mice treated
with 15 and 5 mg/kg b.w. of Ole (G2 and G3) showed a
tendency of lower IL-1β expression, 7.69-fold (P = 0.1)
and 20-fold (P = 0.055), respectively, in comparison to
the infected control. Clearly the IL-1β gene expression
was similar among the infected (G5) and healthy control
(G6) groups.
Moreover, in L. donovani-infected BALB/c mice (G5),
IL-1rn gene expression was 1.7 times diminished (P ≤
0.1) compared to the healthy control group (G6). How-
ever, Ole-treated mice exhibited a tendency for an add-
itional drastic IL-1rn downregulation. Ole treatments of
45, 15, and 5 mg/kg b.w. caused a 20-fold (P = 0.055),
6.67-fold (P = 0.055) and 9.09-fold (P = 0.055) decrease
in IL-1rn expression, respectively, compared to the in-
fected control group (G5; Fig. 7). HePC-treatment also
caused suppressed IL-1rn expression compared to the
infected control group (G5) exhibiting a 5.88-fold down-
regulation (P = 0.037).
The IL-1α gene expression was regulated similarly to
IL-1rn due to L. donovani infection. Healthy BALB/c
mice (G6) exhibited a 2-fold augmented IL-1α transcrip-
tion compared to the infected control group (G5). On
the other hand, Ole-treated mice exhibited significant
increases in IL-1α expression. Ole-treated (45, 15 and
5 mg/kg b.w.) mice showed a 2.67-fold (P = 0.1), 6.22-
fold (P = 0.004) and 4.18-fold (P = 0.037) increase, re-
spectively, compared to the infected control group (G5)
(Fig. 7). The finding that Ole induces the upregulation of
IL-1α gene is important since treatment of L. donovani-
infected mice with HePC (G4), showed reduced, even
though not significantly IL-1α expression.
Levels of TNF-α, IFN-γ, TGF-β1, IL-12β and IL-10 gene
expression
T-cell immune responses are determined by the pre-
dominance of specific cytokines since they regulate T-
cell differentiation [43]. It is known that IL-12β gene is
responsible for the expression of IL-12p40, a basic
Fig. 6 Fold changes log2 of the LdGCLC, mGCLC and NF-kB2 gene
expression in splenocytes of L. donovani-infected BALB/c mice,
3 days after termination of treatments with Ole and HePC. # and *
indicate significant differences compared to the infected and
positive (HePC-treated) control groups, respectively
Fig. 7 Fold changes log2 of the IL-1rn, IL-1b and IL-1a gene
expression in splenocytes of L. donovani-infected BALB/c mice, 3 days
after termination of treatments with Ole and HePC. # and * indicate
significant differences compared to the infected and positive (HePC-
treated) control groups, respectively
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subunit of IL-12 and IL-23 cytokines. IL-12 is necessary
for Th1 polarization and IL-23 is necessary for leishma-
nicidal activity in chronic experimental leishmaniasis
[44]. In our in vivo study, L. donovani infection (G5)
drove into a tendency for repression of IL-12β expres-
sion that reached 51 % (P = 0.055) in comparison to the
healthy control group (G6; Fig. 8). On the contrary, two
of the experimental groups that received Ole (G2 and
G3) exhibited elevated IL-12β gene expression demon-
strating a 4.77-fold (P = 0.025) and 10.15-fold (P = 0.025)
statistically significant increase, respectively, compared
to the infected control group (G5; Fig. 8). Ole-treated
mice of group G1 (45 mg/kg b.w.) exhibited a 3.95-fold
(P = 0.1) IL-12β upregulation in comparison to the infected
control. However, HePC treatment was not able to pro-
mote the IL-12β expression over the infected control (G5).
Changes in IL-10 gene expression in relation to IL-12
expression indicate the orientation of the polarized cell-
mediated immunity towards a Th2 immune response.
Leishmania donovani-infected mice (G5) exhibited a
tendency for increased levels of IL-10 gene transcription
that reached 3.63-times higher levels than in the healthy
control group (G6; P = 0.068; Fig. 8). This elevated ex-
pression of IL-10 gene in splenocytes of infected mice
was not present in treated mice. More specifically, mice
treated with Ole (45, 15 and 5 mg/kg b.w.) showed a
3.85-fold (P = 0.1), 4.17-fold (P = 0.078) and 2.22-fold
(P > 0.1) decrease, respectively, compared to the infected
control group (G5; Fig. 8). Although mice treated with
HePC did not overexpress IL-12β, they exhibited a 5.08-
fold (P = 0.028) significant downregulation in IL-10 tran-
scription compared to the infected control group (G5).
The IFN-γ gene expression in mixed splenocytes of L.
donovani-infected BALB/c mice followed the pattern of
IL-12β expression (Fig. 8). L.donovani-infected mice
(G5) showed a 2-fold upregulation of IFN-γ in compari-
son to the healthy control group (G6). Among Ole-
treated mice, only mice treated with 5 mg/kg b.w. of Ole
exhibited a significant positive fold change (2.25-fold, P =
0.025) in IFN-γ gene expression compared to the infected
control group (G5), whereas HePC treatment downregu-
lated significantly the IFN-γ expression (6.64-fold change;
P = 0.004).
As shown previously, NO production can also be mod-
ulated by a IFN-γ-independent and TNF-α-dependent
mechanism, which is orchestrated by IL-12 [6]. In this
study, we also found that TNF-α expression was upregu-
lated in mice treated with 45 mg/kg b.w. of Ole, which
showed a 2.73-fold change (P = 0.037) compared to the
infected control group (G5; Fig. 8). Mice treated with 15
and 5 mg/kg b.w. of Ole tended into a 2.1-fold (P =
0.078) and a 2.06-fold (P = 0.1) increase of TNF-α ex-
pression in comparison to the infected control
mice. Moreover, L. donovani-infected mice also exhib-
ited a 3.43-fold over transcription of TNF-α expression
compared to the healthy control group (G6), since
TNF-α also participates in the inflammatory process.
HePC treatment had no effect in TNF-α expression
compared to the infected control group (G5).
Finally, the expression of TGF-β1 gene tended into re-
pression (5.18-fold; P = 0.055) due to L. donovani infec-
tion (Fig. 8). On the other hand, Ole-treated groups (15
and 5 mg/kg b.w.) demonstrated a 38.63-fold (P = 0.01)
and 6,34-fold (P = 0.037) upregulated transcription of
Fig. 8 Fold changes log2 of the TNF-α, IFN-γ, TGF-β1, IL-12β and IL-10 gene expression in splenocytes of L. donovani-infected BALB/c mice, 3 days
after termination of treatments with Ole and HePC. # and * indicate significant differences compared to infected and positive (HePC-treated)
control groups, respectively
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TGF-β1 in comparison to the infected control group
(G5). Mice treated with 45 mg/kg b.w. presented a ten-
dency of 9.66-fold (P = 0.1) increased TGF-β1 gene tran-
scription levels. Finally, HePC treatment did not
significantly alter the TGF-β1 expression over L. dono-
vani infection.
Tbx21 and GATA3 transcription factors gene expression
The modulating action of Ole in the expression of spe-
cific genes in splenocytes of L. donovani-infected BALB/
c mice, prompted us to investigate the expression of
transcription factors, Tbx21 and GATA3, which are re-
sponsible for cell-mediated immune response polarization
toward the Th1 or Th2 phenotype, respectively [4].
Three days after treatment termination the Tbx21/
GATA3 gene expression ratio was significantly increased
in Ole-treated mice (Ole 15 mg/kg b.w.; 2.75-fold
change; P = 0.004) compared to the infected control
group (Fig. 9). This augmented Tbx21/GATA3 ratio in
Ole-treated mice was a result of downregulation in
GATA3 expression rather than the corresponding upreg-
ulation in Tbx21 expression. It is noteworthy, that mice
of the infected control group as well as of the healthy
control group exhibited a similar Tbx21/GATA3 ratio.
Delayed type hypersensitivity (intradermal reaction to L.
donovani promastigote lysate)
A DTH assay can detect the in vivo development of a
specific cellular response against the intradermally inoc-
ulated antigen where a positive reaction is manifested by
swelling and erythema at the site of administration.
Three days after termination of treatment with 15 mg/kg
of b.w. of Ole, we intradermally administered soluble
Leishmania antigen in the footpad of L. donovani-infected
as well as healthy control BALB/c mice (Fig. 9). After
24 h, the footpad swelling was 2.33 ± 0.95 mm in Ole-
treated mice and 0.17 ± 0.35 mm in the infected control
group (P = 0.001, Fig. 9). At 48 h, the differences between
groups were sustained and this disclosed the in vivo
operation of a parasite specific cell-mediated immunity
(2 ± 0.60 mm in Ole-treated mice and 0.11 ± 0.22 mm
in infected control mice; P < 0.0001).
Discussion
Ole had been previously shown to exhibit antiparasitic
activity against L. donovani amastigotes in J774A.1 mac-
rophages. This finding is further associated with elevated
Ole-induced intracellular and extracellular oxidative
stress (ROS and NO production) in non-infected or in-
fected J774A.1 macrophages, as shown in the present
study. It is of great interest that Ole per se as well as its
co-administration with LPS, generated limited oxidative
stress in non-infected J774A.1 cells and these findings
could probably be attributed to the different concentra-
tions of Ole and to its in vitro antioxidant effect [45, 46].
In contrast, when J774A.1 cells were infected with L.
donovani parasites, Ole induced significant production
of ROS, although it has been reported that monocytes of
patients with active visceral leishmaniasis exhibited de-
creased NADH-oxidase and NADPH-oxidase activity
compared to healthy controls from endemic and non-
endemic areas [16]. Data described in the present study
showed that Ole at low concentrations behaved as an
antioxidant, by reducing the production of ROS caused
Fig. 9 Tbx21/GATA3 gene expression ratios in splenocytes (cross-hatched bars) and delayed type hypersensitivity (DTH, shaded bars) in L. donovani-infected
BALB/c mice, untreated or treated with 15 mg/kg b.w. of Ole, measured at 3 days after treatment termination. The Y-axis represents both the Tbx21/GATA3
ratio (unitless) and the difference in skin thickness after the reaction (mm). At each time point in the DTH assay, the values represent the
thickness after a reaction to the Leishmania antigen minus the thickness in the saline control. #indicates significant differences compared
to the infected control group
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by the presence of LPS, whereas Ole at high concentra-
tions, promoted J774A.1 activation by elevating the gen-
eralized oxidative stress (increased levels of ROS and
NO production).
These results are in accordance with other studies of
anti-leishmanial agents from natural resources. For ex-
ample, Piper betle L. (Piperaceae) crude extract augmented
ROS levels when incubated with L. donovani-infected
J774A.1 cells following a time dependent increase up to
24 h [47]. However, this result conflicted with other studies,
which highlighted the antioxidant activity of P. betle [48].
Moreover, luteolin, a well-studied plant derived biophenol,
although showing a satisfactory action against L. donovani
amastigotes [49], reduced NO production in RAW264.7
macrophages incubated with LPS [50]. Ole as well as res-
veratrol, are natural compounds with opposed actions, anti-
oxidants or pro-oxidants. This dual action could possibly
be attributed to their metabolic activation through a metal
ion (e.g. Cu+2) chelation [51–54]. Indeed metal ions are typ-
ically present in biological systems or as contaminants in
biological reagents and the chelation of these ions can pro-
duce toxic pro-oxidants, capable of inducing oxidative
stress in infected macrophages.
Thus, the ability of several active compounds obtained
from plant extracts or isolated compounds to act as
growth inhibitors of promastigotes and amastigotes in in
vitro systems, led to the investigation of their role in in
vivo protocols that delineate their biological effect in
depth. Numerous studies are focused on the mecha-
nisms possessed by natural products used in traditional
medicine, in order to affect the immune system. Their
effect vary in inducing different immune mediators such
as cytokines and chemokines resulting in the establish-
ment of a protective immune response that will provide
effective parasite elimination without producing excessive
tissue destruction. Thereafter, we evaluated the effect of
Ole in an in vivo murine model of visceral leishmaniasis.
Our data showed that soon after Ole treatment termin-
ation (at 3 days), splenocytes obtained from L. donovani-
infected BALB/c mice, exhibited significant intracellular
ROS production and increased levels of NO in the super-
natants of splenocytes and hepatocytes. Similarly, other
natural products, such as asiaticoside and fucoidan, also
produce high levels of ROS and NO in splenocytes of L.
donovani-infected mice, and these findings explain the
diminution of the parasite burden in the spleen [55, 56]. It
is noteworthy that Ole induced more potent production
of oxygen intermediates in L. donovani-infected mice,
compared to HePC, the first oral drug approved for the
treatment of visceral leishmaniasis. HePC was found to
support solely the production of NO from spleen and liver
cells at 3 days after the termination of treatment.
Excessive production of ROS may lead to oxidative
stress, loss of cell function and ultimately apoptosis or
necrosis [21]. Thus, a balance between oxidant and anti-
oxidant intracellular systems is vital for cell function and
regulation. Mammalian cells and Leishmania parasites
are able to counteract oxidative stress through GSH and
TSH production, respectively [57]. In our in vivo model
of experimental visceral leishmaniasis, we found no sig-
nificant changes in total or free GSH levels in the liver
among all experimental groups (data not shown). This
finding highlighted the notion that infected liver cells
were protected from the oxidative stress induced by Ole.
Previous studies have shown that Ole could in vitro
replenish the GSH pool of J774A.1 macrophages by re-
storing glutathione reductase and peroxidase activity, as
well as by inducing their mRNA expression [32]. In the
present study, we examined the effect of Ole on the
expression of the catalytic subunit of the glutamate-
cysteine ligase (GCLC) in host splenocytes and parasite
cells. GCLC is a rate-limiting enzyme in GSH and TSH
synthesis in mammalian cells and parasites, respectively.
Transgenic promastigotes heterozygous for GCLC (L.
donovani GCLC+/-) exhibited diminished TSH levels,
which rendered parasites more vulnerable to oxidative
stress in vitro with decreased survival ability inside acti-
vated macrophages [23]. Moreover, other studies have
shown differences in host and parasite GCLC gene regu-
lation when sodium stibogluconate (SSG)-sensitive or
SSG-resistant L. donovani parasites were treated with
SSG [38]. The transcription regulation of GCLC gene is
also found to be organ-specific since augmentation of
murine GCLC expression only occurs in the spleen [38].
However, increases in mGCLC expression appeared to
protect SSG-resistant L. donovani parasites, which abro-
gated the need for parasites to recruit additional “defen-
sive measurements” such as LdGCLC upregulation [38].
In the absence of SSG, SSG-resistant L. donovani para-
sites could downregulate mGCLC and upregulate the
LdGCLC expression. This capacity allowed parasites to
elevate their oxidative stress resistance, because TSH has
600-fold greater affinity for NO• compared to GSH [22,
38]. In our study, Ole-treated groups exhibited differen-
tial mGCLC and LdGCLC expression, 3 days after treat-
ment termination where LdGCLC and mGCLC expression
was downregulated and upregulated, respectively. On the
contrary, in HePC-treated mice, as well as in infected con-
trol mice, mGCLC and LdGCLC genes were regulated in-
versely. This expression profile supported the parasite
need to dodge the oxidative burst with defensive mecha-
nisms. In contrast, Ole appeared to function in both
systems, because it maintained LdGCLC expression at low
levels, rendering parasites susceptible to oxidative burst,
and at the same time, assisting the host cell in neutralizing
ROS and RNI production.
NF-kB proteins are a family of transcription factors
with great importance in inflammation and immunity
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[58]. ROS have been reported to both activate and to re-
press NF-kB signaling. At the cellular level, the NF-kB2
gene, that encodes the NF-kB p100 subunit, is primarily
upregulated by inflammatory lymphokines, such as IL-
1β and TNF-α; however, the activation of NF-kB p50/
p65 heterodimers by various stimuli (including ROS)
can also autoregulate NF-kB2 expression [59, 60]. In our
study, NF-kB2 expression in splenocytes from treated
mice (Ole- or HePC-treated) remained at similar levels
compared to the healthy control group, even though
Ole-treated mice exhibited augmented oxidative stress,
3 days after treatment termination. In contrast, spleno-
cytes from infected control mice exhibited upregulated
expression of NF-kB2 possibly due to the significant up-
regulation of IL-1β expression. Thus, all of the above re-
sults indicate that splenocytes of Ole-treated mice are
adequate to eliminate intracellular parasites via ROS and
NO-dependent mechanisms, in the absence of excessive
inflammation in the environment of splenocytes, as indi-
cated by the absence of NF-kB2 upregulation and the
enhanced IL-1β downregulation [21, 59].
Moreover, Ole treatment resulted in the downregula-
tion of both IL-1β and IL-1rn, in combination with IL-1α
upregulation. The above data indicate that in Ole-
treated mice the only member of the IL-1 cytokine fam-
ily available for binding to the IL-1 receptor was IL-1α,
because IL-1β and IL-1rn were selectively downregu-
lated, a finding that has not been described before in
experimental visceral leishmaniasis [61]. In contrast, it is
already known that IL-1α requires TNF-α for optimal in-
duction of the Th1-type cytokine IL-12 in susceptible
BALB/c mice [62], an effect that was also found in our
study since Ole-treated mice overexpressed all three cy-
tokines in their spleen. On the other hand, L. donovani
parasites could not modulate IL-1α, in either susceptible
BALB/c mice or resistant C3H/HeN mice [63]. More-
over, IL-1α seemed to be less important than IL-1β as an
inflammatory cytokine in parasitic dissemination. In-
deed, IL-1α-/- mice were more resistant than IL-1β-/-
mice in the experimental visceral leishmaniasis model
[34]. In addition, splenocytes from IL-1α-/- mice failed to
mount a Th1 polarization in the later stages of acute
infection compared to IL-1β-/- splenocytes [34]. The ob-
served anti-inflammatory activity of Ole through repres-
sion of IL-1β gene seems to be very important in the
first steps of experimental visceral leishmaniasis, since
IL-1β was found to be in greater necessity for CD4+
polarization to the Th2 phenotype than IL-1α [34]. The
Th2 cell-mediated immune response to L. donovani in-
fection is triggered and established by IL-1β through a
well-established mechanism that enables PGE2 induc-
tion via COX-2 upregulation, [11, 64]. In this study, Ole
suppressed the expression of IL-1β, an effect also found
in LPS-stimulated human peripheral blood mononuclear
cells, where Ole was incapable of altering IL-6, TNF-α
and PGE2 levels [33].
In the present study, we demonstrated the ability of
Ole to initiate a Th1 cell-mediated immune response in
a murine model of visceral leishmaniasis. This immuno-
modulatory effect of Ole is highlighted in the IL-12/IL-
10 ratio, which represents a marker of disease severity in
leishamaniasis [65]. More specifically, all of the Ole-
treated experimental groups exhibited significantly
higher IL-12β and lower IL-10 gene expression than the
infected control group. The ability of splenocytes from
Ole-treated BALB/c mice to express IL-12β is of para-
mount importance, as it has been previously shown that
IL-12 is intrinsically linked to protection against visceral
leishmaniasis [66]. Moreover, at this time point, we did
not find an elevated IL-12β expression in HePC-treated
mice. Furthermore, we found that Ole-treated mice ex-
hibited elevated TNF-α and IFN-γ gene expression.
Therefore, these elevated gene expression levels might
be responsible for the diminished parasite burden, the
augmented ROS and NO levels and the upregulated
iNOS gene expression (data not shown) found in Ole-
treated splenocytes.
On the other hand, we observed augmented expression
of the TGF-β1 gene which transcripts a cytokine charac-
terized by its immunosuppressive activity [67, 68]. How-
ever, TGF-β was found to play a leading role in IL-12-/-
and IL-12-/-/IFN-γ-/- C57BL/6 mice that could not mount
a Th1 immune response [69]. Also, TGF-β-producing
Tregs were essential for an effective secondary immune
response against Leishmania parasites since Treg elimin-
ation in BALB/c mice resulted in a Th2 immunological
phenotype and the deterioration of leishmaniasis [70].
All of the above findings indicate that Ole treatment
in L. donovani-infected BALB/c mice could indirectly or
directly modulate the immune response. This result is
further confirmed by the highly elevated Leishmania-
specific IgG2a/IgG1 ratios found in the serum of Ole-
treated mice. This IgG2a overproduction was also
evident at 6 weeks after treatment termination. In con-
trast, infected control mice had IgG2a/IgG1 ratios close
to 0.5, which indicate a dominance of the Th2 immune
response. This immunoglobin production switch from
IgG1 to IgG2a is typically driven by IL-12 and IFN-γ
produced by Th1 cells [71–73].
We further assessed the Th1/Th2 mixed cellular im-
mune response by determining the gene expression of the
Tbx21 and GATA3 transcription factors. An experimental
model of visceral leishmaniasis in BALB/c mice typically
exhibits a Th1/Th2 mixed immunological response. The
Tbx21/GATA3 gene expression ratio reflects the prevailing
polarization. GATA3 gene expression is predominantly
important for Th2 immune response, because its inhib-
ition will result in Tbx21 expression, which is stimulated
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by Th1 cytokines, like IL-12 and IFN-γ [5, 6]. In our in
vivo experiments, Ole treatment caused an upregulation
of Tbx21 over GATA3, which enables a dominance of Th1
cellular immune response in the spleen. This finding was
consistent with the cytokine gene expression profile de-
scribed previously. Next, we performed the DTH test, as
an index of cell-mediated immunity, in mice treated with
Ole, to assess its effect in promoting enhanced phagocyt-
osis of the infected host leading to effective parasite elim-
ination. Strong DTH responses significantly reduce
parasite burden and thus are important in host defense
mechanisms against Leishmania infections. We found that
BABL/c mice treated with Ole developed positive DTH
response maximized at 24 h that is predictive of their cap-
acity to resolve the infection.
Conclusions
In conclusion, we showed that Ole is able to induce
ROS production in an in vitro, as well as in an in vivo
model of visceral leishmaniasis. Moreover, Ole augments
NO production in ex vivo cultures of spleen and liver
cells. The induced oxidative burst is mediated in the
host by the regulation of glutathione-related genes, and
at the same time, Ole renders parasites vulnerable by
diminishing the expression of their respective TSH-
producing enzymes. These diverse activities are accompan-
ied by the intense downregulation of IL-1β and IL-1rn
genes, but not IL-1α, which allows the NF-kB2 expression
despite the oxidative stress. Ole treatment downregulates
IL-10 gene expression, and in combination with IL-12β
overexpression, drives a predominant Th1 polarization that
is accompanied with IFN-γ and TNF-α overtranscription.
This Leishmania protective cell-mediated immune re-
sponse was clearly demonstrated by the positive DTH reac-
tion, the ratio of Tbx21/GATA3 transcription factors and
Leishmania-specific IgG2a/IgG1 antibodies, indicating the
operation of a Th1 type of immune response. On the other
hand HePC was unable to modulate the majority of the
genes tested since, as mentioned previously, its main route
of action is through lipid metabolism [74]. The immuno-
modulatory effect of HePC seems to involve IFN-γ receptor
and IFN-γ responsiveness through STAT1 phosphorylation
taking advantage of the endogenous IFN-γ levels [75].
Thus, the diminished parasite burdens that both Ole and
HePC presented in our previous study [29], is a result of
different mechanisms. Finally, the present study illustrated
the promising therapeutic properties of Ole as a natural
product with leishmanicidal activity and immunomodula-
tory effects that are mainly triggered by its anti-
inflammatory and antioxidative effects towards the benefit
of the infected host.
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NADH, Nicotinamide adenine dinucleotide; NADPH, Nicotinamide adenine
dinucleotide phosphate; NF-kB2, subunit 2 of nuclear factor kappa-B; NO, nitric
oxide; Ole, oleuropein; PBS, phosphate-buffered saline; PGE2, prostaglandin E2;
RNI, reactive nitrogen intermediates; ROS, reactive oxygen species; SLA, soluble
Leishmania antigen; STAT1, signal transducer and activator of transcrip-
tion 1; Tbx21, T-box transcription factor; TGF-β1, transforming growth
factor beta-1; Th, T helper; TNF-α, tumor necrosis factor-α; Tregs, regula-
tory T cells; TSH, trypanothione; USFDA, United States Food and Drug
Administration Agency
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